.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 3,908,010

« Back to Dashboard

Details for Patent: 3,908,010

Title: Basically substituted heterocycles as anti-emetics
Abstract:Certain 11-basically substituted dibenzo?b,f!-?1,4!thiazepines and dibenzo?b,e! ?1,4!diazepines are useful as anti-emetics.
Inventor(s): Schmutz; Jean (Muri, CH), Hunziker; Fritz (Bern, CH)
Assignee: Wander; Dr. A. (Bern, CH)
Filing Date:Jan 22, 1974
Application Number:05/435,430
Claims:1. A method for treating emesis, which comprises enterally or parenterally administering to a mammal in need of said treatment an anti-emetic effective amount of a compound of the formula: ##EQU12## and pharmaceutically acceptable acid additional salts thereof, where Z denotes sulphur, R.sub.1 represents hydrogen, allyl, alkyl containing not more than 3 carbon atoms, hydroxyalkyl containing not more than 3 carbon atoms, alkoxyalkyl containing not more than 6 carbon atoms or alkoyloxyalkyl containing not more than 6 carbon atoms and R.sub.2 and R.sub.3 are the same or different and represent hydrogen or methyl.

2. A method according to claim 1 in which the compound is 2-dimethylaminosulphonyl-11-(4-methyl-1-piperazinyl)-dibenzo?b,f!?1,4!-thi azepine.

3. A method according to claim 1 wherein the compound is administered to a mammal in need of said treatment at a daily dose of from about 5 milligrams to about 400 milligrams.

4. A method according to claim 1 wherein the compound is administered to a mammal in need of said treatment in a unit dosage form comprising said compound to the extent of from about 10 milligrams to about 25 milligrams per unit dosage.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc